rapid
specif
sensit
detect
bacteri
pathogen
essenti
toward
clinic
manag
infecti
diseas
tradit
approach
pathogen
detect
howev
often
requir
timeintens
bacteri
cultur
amplif
procedur
herein
microparticl
enhanc
doublestrand
dna
probe
demonstr
rapid
speciesspecif
detect
bacteri
rrna
molecular
assay
bind
target
sequenc
fluorophor
conjug
probe
thermodynam
displac
quencher
probe
allow
fluorophor
fluoresc
incorpor
streptavidinco
microparticl
local
biotinyl
probe
sensit
assay
improv
order
magnitud
limit
detect
assay
eight
bacteria
without
target
amplif
highli
specif
common
pathogen
applic
toward
clinic
diagnost
demonstr
directli
identifi
bacteri
pathogen
urin
sampl
patient
urinari
tract
infect
infecti
diseas
caus
bacteri
pathogen
major
healthcar
challeng
worldwid
instanc
urinari
tract
infect
uti
common
bacteri
infect
organ
system
account
seven
million
offic
visit
one
million
hospit
admiss
year
clinic
manag
infecti
diseas
identif
quantif
bacteri
pathogen
patientderiv
sampl
requir
assess
sever
infect
standard
method
identifi
pathogen
agent
clinic
sampl
urin
uti
requir
transport
sampl
central
microbiolog
laboratori
overnight
cultur
bacteri
coloni
count
identifi
base
morpholog
phenotyp
paramet
major
shortcom
standard
culturebas
diagnost
approach
signific
delay
least
day
sampl
collect
result
report
absenc
definit
microbiolog
diagnosi
larg
driven
overand
misus
antibiot
develop
specif
sensit
molecular
biosens
techniqu
rapid
detect
bacteri
pathogen
would
revolution
clinic
practic
uti
infecti
diseas
allow
evidencebas
rather
empir
manag
infecti
diseas
effect
treatment
patient
varieti
molecular
biosens
techniqu
southern
blot
polymeras
chain
reaction
pcr
dna
microarray
nucleic
acid
sequencebas
amplif
mass
spectroscopi
immunoblot
adopt
detect
bacteri
pathogen
genotyp
proteom
approach
allow
highli
sensit
specif
detect
bacteri
pathogen
hand
develop
rapid
bacteri
detect
strategi
toward
pointofcar
applic
receiv
increas
attent
due
time
labor
intens
protocol
associ
exist
assay
particular
assay
free
separ
amplif
bacteri
cultur
highli
desir
assay
could
dramat
simplifi
assay
protocol
facilit
rapid
diagnost
resourcelimit
set
doublestrand
dna
dsdna
probe
homogen
assay
rapid
detect
specif
nucleic
acid
sequenc
potenti
appli
pathogen
identif
dsdna
sens
scheme
dna
sequenc
contain
fluorophor
label
end
design
complementari
nucleotid
sequenc
interest
allow
homogen
detect
target
complementari
sequenc
design
respect
fluorophor
probe
shorter
length
end
label
quencher
absenc
target
fluorophor
quencher
probe
close
proxim
diminish
fluoresc
signal
target
quencher
probe
replac
due
thermodynam
driven
bind
event
fluorophor
probe
target
therefor
fluorophor
separ
quencher
abl
fluoresc
compar
homogen
assay
nucleic
acid
molecular
beacon
advantag
dsdna
probe
includ
possibl
adjust
quenchertofluorophor
ratio
nois
minim
flexibl
modifi
length
quencher
sequenc
sticki
end
improv
specif
kinet
assay
dsdna
probe
demonstr
variou
biomed
applic
includ
detect
singl
nucleotid
mismatch
quantif
pcr
product
quantif
dna
bind
protein
howev
dsdna
assay
requir
target
amplif
pcr
improv
sensit
applic
dsdna
probe
rapid
detect
bacteri
pathogen
demonstr
partial
due
limit
sensit
assay
often
result
strong
background
biolog
sampl
wash
step
involv
homogen
assay
particularli
challeng
detect
pathogen
clinic
sampl
urin
serum
known
strong
matrix
effect
repres
major
technic
hurdl
appli
dsdna
probe
homogen
assay
quantifi
bacteri
pathogen
without
amplif
bacteri
cultur
tackl
abovement
challeng
present
rapid
molecular
approach
detect
bacteri
pathogen
use
microparticl
conjug
dsdna
probe
figur
show
overal
concept
detect
scheme
achiev
specif
pathogen
identif
dsdna
probe
design
complementari
speciesspecif
ribosom
rna
rrna
target
pathogen
copi
bacterium
detect
bacteri
ribosom
rna
molecul
allow
specif
pathogen
identif
also
high
sensit
due
high
copi
number
rrna
bacterium
improv
sensit
assay
without
target
amplif
streptavidin
coat
microparticl
appli
enhanc
perform
assay
particular
end
fluorophor
probe
label
biotin
multipl
probe
captur
streptavidin
coat
microparticl
result
assembl
bring
larg
number
fluorophor
probe
small
region
significantli
increas
intens
facilit
manipul
studi
dsdna
probe
specif
detect
escherichia
coli
e
coli
account
uncompl
uti
design
explor
microparticl
enhanc
molecular
assay
pathogen
detect
signaltonois
ratio
assay
first
optim
adjust
quenchertofluorophor
ratio
analyt
sensit
dynam
rang
dsdna
probe
without
microparticl
determin
use
synthet
target
uropathogen
e
coli
clinic
isol
analyt
specif
assay
test
common
pathogen
includ
staphylococcu
saprophyticu
saprophyticu
enterococcu
speci
spp
proteu
mirabili
p
mirabili
addit
applic
molecular
assay
clinic
test
evalu
use
urin
sampl
uti
patient
proof
concept
uropathogen
clinic
isol
includ
e
coli
saprophyticu
enterococcu
spp
p
mirabili
e
coli
strain
appli
experi
uropathogen
clinic
isol
obtain
four
differ
patient
document
urinari
tract
infect
e
coli
bacteria
inocul
luria
broth
lb
shaker
grown
cfuml
bacteria
mix
glycerol
bd
md
store
saprophyticu
enterococcu
spp
p
mirabili
cultur
lb
overnight
dilut
cfuml
experi
two
deidentifi
infect
clinic
urin
sampl
test
evalu
applic
assay
clinic
diagnost
patient
age
male
histori
spinal
cord
injuri
sampl
contain
singl
speci
uropathogen
one
sampl
cfuml
e
coli
sampl
cfuml
p
mirabili
sampl
aliquot
upon
sampl
receipt
sampl
pellet
centrifug
min
microfug
supernat
remov
pellet
snap
frozen
dri
ice
store
clinic
isol
urin
sampl
collect
approv
stanford
univers
va
palo
alto
health
care
system
vapahc
institut
review
board
identif
microorgan
perform
vapahc
clinic
microbiolog
laboratori
one
set
dsdna
probe
design
evalu
assay
studi
oligonucleotid
probe
target
rrna
design
use
primros
ribosom
databas
project
releas
probe
select
verifi
align
rdna
sequenc
ncbi
use
geneiou
confirm
bacteri
clinic
isol
vapahc
fluorophor
probe
design
bind
specif
loop
region
rrna
quencher
probe
complementari
fluorophor
probe
fluorophor
quencher
sequenc
e
coli
probe
base
length
respect
previous
shown
length
optim
improv
thermodynam
driven
replac
target
quencher
reduct
nonspecif
bind
fluorophor
probe
label
biotin
fluorophor
tamra
nh
ester
end
respect
fluorophor
excit
nm
emiss
peak
nm
quencher
probe
label
iowa
black
rq
end
chosen
base
high
quench
effici
tamra
addit
e
coli
probe
set
random
probe
design
control
case
microparticl
enhanc
dsdna
assay
streptavidinco
particl
wv
nmolmg
bind
site
capac
bind
molecul
per
particl
ad
supernat
figur
support
inform
addit
detail
experiment
protocol
found
support
inform
tabl
support
inform
summar
probe
design
studi
disassoci
free
fluorophor
probe
quencher
probe
major
sourc
background
nois
repres
major
factor
limit
overal
sensit
dsdna
assay
order
minim
background
level
concentr
quencher
probe
rel
concentr
fluorophor
probe
quenchertofluorophor
ratio
adjust
systemat
minim
concentr
free
fluorophor
probe
solut
figur
support
inform
background
fluoresc
gener
diminish
quenchertofluorophor
ratio
fluoresc
intens
minim
quenchertofluorophor
ratio
reach
ratio
increas
ratio
show
signific
reduct
fluoresc
intens
higher
quenchertofluorophor
ratio
affect
probe
sensit
shift
dynam
rang
higher
target
concentr
consist
previou
theoret
experiment
studi
ratio
allow
high
signaltonois
ratio
furthermor
two
differ
fluorophor
excit
nmemiss
nm
tamin
excit
nm
emiss
nm
examin
reduc
background
nois
experi
tamin
shown
better
signaltonois
ratio
data
shown
like
result
strong
autofluoresc
cellular
compon
well
bacteri
growth
media
shorter
wavelength
result
tamin
use
experi
perform
dsdna
probe
without
microparticl
first
character
evalu
use
assay
rapid
molecular
analysi
without
target
amplif
figur
show
titrat
curv
dsdna
probe
detect
synthet
target
fluoresc
intens
gener
increas
concentr
target
larg
dynam
rang
span
sever
order
magnitud
concentr
consist
previou
analys
dsdna
probe
probe
concentr
nm
synthet
target
detect
nanomolar
picomolar
rang
lod
assay
estim
pm
tabl
support
inform
evalu
abil
bacteri
detect
conduct
experi
dsdna
probe
detect
rrna
e
coli
result
shown
figur
titrat
curv
detect
bacteri
rrna
display
similar
trend
compar
titrat
curv
detect
synthet
target
dynam
rang
assay
cfu
lod
cfu
volum
sampl
tabl
support
inform
equival
approxim
cfuml
pm
assum
copi
rrna
bacterium
result
good
agreement
lod
determin
use
synthet
target
suggest
dsdna
probe
effect
detect
bacteri
rrna
improv
sensit
assay
microparticl
coat
streptavidin
appli
microparticleenhanc
dsdna
probe
aim
improv
sensit
local
target
concentr
small
region
figur
support
inform
figur
show
intens
microparticl
enhanc
dsdna
probe
differ
concentr
synthet
target
gener
microparticleenhanc
dsdna
probe
achiev
higher
signal
mere
dsdna
probe
everi
singl
target
concentr
test
similarli
assay
dynam
rang
across
sever
order
magnitud
concentr
util
microparticl
minimum
target
concentr
distinguish
background
nois
order
femtomolar
statist
analysi
show
lod
assay
fm
better
achiev
dsdna
probe
tabl
support
inform
result
suggest
microparticl
provid
simpl
effect
approach
enhanc
sensit
dsdna
probe
assay
without
target
amplif
microparticl
enhanc
assay
also
evalu
capabl
detect
e
coli
result
shown
figur
similar
synthet
target
experi
observ
signific
improv
sensit
assay
compar
dsdna
probe
alon
lod
assay
estim
cfu
sampl
ie
cfuml
equival
fm
rrna
data
show
incorpor
microparticl
significantli
improv
sensit
dsdna
probe
assay
requir
less
bacteria
pathogen
identif
investig
specif
microparticl
enhanc
dsdna
probe
specif
assay
evalu
three
common
uropathogen
bacteria
includ
saprophyticu
enterococcu
spp
p
mirabili
result
shown
figur
experi
signal
pathogen
statist
distinguish
background
show
dsdna
probe
excel
specif
bacteria
fact
probe
sequenc
previous
demonstr
specif
e
coli
bacteria
electrochem
format
result
support
bacteri
rrna
specif
detect
dsdna
probe
incorpor
microparticl
compromis
specif
probe
sequenc
major
challeng
molecular
diagnost
use
physiolog
sampl
matrix
effect
effect
compon
sampl
target
analyt
convent
assay
bacteri
detect
requir
timeconsum
bacteri
cultur
step
isol
target
bacteria
sampl
matrix
avoid
cultur
step
rapid
detect
molecular
assay
pointofcar
diagnost
insensit
matrix
effect
test
abil
microparticl
enhanc
dsdna
assay
detect
bacteria
directli
physiolog
sampl
two
clinic
urin
sampl
uti
patient
cfuml
e
coli
cfuml
p
mirabili
bacteria
respect
test
figur
rel
intens
clinic
urin
sampl
e
coli
significantli
higher
p
mirabili
bacteria
neg
control
intens
sampl
p
mirabili
distinguish
signal
neg
control
result
indic
microparticl
enhanc
assay
capabl
specif
detect
target
bacteria
urin
affect
matrix
effect
evolut
biosensor
system
develop
practic
costeffect
approach
procedur
easi
implement
high
sensit
great
import
diseas
diagnost
applic
within
context
demonstr
homogen
dsdna
probe
rapidli
quantifi
bacteria
bacteri
rrna
chosen
target
molecular
analysi
due
high
copi
number
bacteria
moreov
rrna
gene
sequenc
well
character
region
interspeci
divers
use
probe
design
differenti
differ
bacteri
speci
proof
concept
design
dsdna
probe
e
coli
test
clinic
isol
urin
sampl
uti
patient
demonstr
studi
probe
good
specif
common
bacteria
sampl
matrix
clinic
sampl
best
knowledg
first
demonstr
applic
dsdna
probe
specif
detect
bacteri
rrna
compar
hybrid
assay
detect
speciesspecif
bacteri
rrna
dsdna
probe
dramat
simplifi
assay
protocol
particularli
suitabl
resourc
limit
set
rural
clinic
temporari
clinic
disast
zone
also
demonstr
enhanc
sensit
dsdna
probe
util
microparticl
local
probe
result
show
combin
microparticl
dsdna
probe
lead
highli
sensit
specif
optic
biosensor
bacteria
identif
quantif
small
sampl
volum
assay
detect
limit
report
term
absolut
number
bacteria
instead
bacteri
concentr
without
microparticl
assay
requir
bacteria
pathogen
identif
molecular
probe
local
microparticl
sensit
probe
improv
similar
concept
appli
molecular
beaconlabel
microspher
assay
detect
synthet
nucleic
acid
sequenc
mimic
sar
coronaviru
hand
demonstr
microparticl
combin
dsdna
probe
improv
sensit
order
magnitud
less
bacteria
requir
pathogen
identif
improv
sensit
allow
direct
detect
bacteria
without
overnight
cultur
target
amplif
procedur
advantag
microparticl
enhanc
dsdna
assay
includ
short
assay
time
simplic
assay
protocol
characterist
essenti
consider
pointofcar
applic
total
assay
time
sampletoresult
less
min
includ
sampl
centrifug
min
bacteri
lysi
min
probe
hybrid
min
target
local
microparticl
min
signific
reduct
compar
day
standard
cultur
base
approach
potenti
reduc
autom
use
microfluid
techniqu
implement
microparticl
enhanc
dsdna
assay
use
microfluid
also
facilit
multiplex
detect
sampl
preconcentr
antimicrobi
suscept
test
final
small
volum
sampl
requir
assay
particularli
use
larg
amount
sampl
avail
diagnost
pediatr
popul
studi
develop
demonstr
microparticl
enhanc
dsdna
assay
quantit
detect
bacteria
high
sensit
specif
result
suggest
assay
directli
appli
clinic
diagnost
applic
although
larger
scale
clinic
valid
studi
greater
number
clinic
sampl
requir
determin
diagnost
sensit
specif
rapid
simplic
small
volum
requir
assay
potenti
appli
variou
biomed
applic
pathogen
identif
urinari
tract
infect
sepsi
diagnost
neonat
intens
care
unit
refer
web
version
pubm
central
supplementari
materi
schemat
microparticl
conjug
dsdna
probe
detect
specif
nucleic
acid
sequenc
exist
target
fluorophor
probe
thermodynam
driven
hybrid
target
replac
quencher
probe
probe
captur
streptavidin
coat
microparticl
titrat
curv
dsdna
probe
determin
use
synthet
dna
target
insert
show
intens
lower
concentr
rang
pm
fm
titrat
curv
dsdna
probe
determin
use
e
coli
bacteria
insert
show
intens
lower
concentr
rang
cfu
cfu
titrat
curv
microparticleenhanc
dsdna
probe
determin
use
synthet
dna
target
insert
show
intens
lower
concentr
rang
pm
fm
titrat
curv
microparticleenhanc
dsdna
probe
determin
use
e
coli
bacteria
insert
show
intens
lower
concentr
rang
cfu
cfu
specif
microparticl
conjug
probe
detect
bacteria
clinic
urin
sampl
three
sampl
test
includ
urin
cfuml
e
coli
urin
cfuml
p
mirabili
neg
control
